LRMP | Lymphoid-restricted membrane protein | Cytoskeleton related proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
LTF | Lactotransferrin | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
LY86 | Lymphocyte antigen 86 | Predicted secreted proteins
| | | | | Tissue enhanced |
MAP4K1 | Mitogen-activated protein kinase kinase kinase kinase 1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
MARCO | Macrophage receptor with collagenous structure | Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
MKI67 | Marker of proliferation Ki-67 | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
MMP9 | Matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MTFR2 | Mitochondrial fission regulator 2 | Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
MYBL2 | V-myb avian myeloblastosis viral oncogene homolog-like 2 | Cancer-related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
MYO1F | Myosin IF | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
MYO1G | Myosin IG | Predicted intracellular proteins
| | | | | Tissue enhanced |
NCF1 | Neutrophil cytosolic factor 1 | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
NKG2-E | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000437563} | Predicted membrane proteins
| | | | | Tissue enhanced |
NOXO1 | NADPH oxidase organizer 1 | FDA approved drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
OSBP2 | Oxysterol binding protein 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
P2RY13 | Purinergic receptor P2Y, G-protein coupled, 13 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
PAX5 | Paired box 5 | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
PDCD1 | Programmed cell death 1 | CD markers Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
PF4V1 | Platelet factor 4 variant 1 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
PITPNM3 | PITPNM family member 3 | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
PLCG2 | Phospholipase C, gamma 2 (phosphatidylinositol-specific) | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |
PLEK | Pleckstrin | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
PSTPIP1 | Proline-serine-threonine phosphatase interacting protein 1 | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
PSTPIP2 | Proline-serine-threonine phosphatase interacting protein 2 | Cytoskeleton related proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
PTGS2 | Prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | Cancer-related genes Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
PTPN7 | Protein tyrosine phosphatase, non-receptor type 7 | Cytoskeleton related proteins Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
PTPRCAP | Protein tyrosine phosphatase, receptor type, C-associated protein | Predicted secreted proteins
| | | | | Tissue enhanced |
PVRIG | Poliovirus receptor related immunoglobulin domain containing | Predicted membrane proteins
| | | | | Tissue enhanced |
RASAL3 | RAS protein activator like 3 | Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |
RCSD1 | RCSD domain containing 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
RECQL4 | RecQ protein-like 4 | Cancer-related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
RENBP | Renin binding protein | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
RP11-872D17.8 | Uncharacterized protein {ECO:0000313|Ensembl:ENSP00000431536} | Predicted membrane proteins
| | | | | Tissue enhanced |
RUNX3 | Runt-related transcription factor 3 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
SASH3 | SAM and SH3 domain containing 3 | Predicted intracellular proteins
| | | | | Tissue enhanced |
SCIMP | SLP adaptor and CSK interacting membrane protein | Predicted membrane proteins
| | | | | Tissue enhanced |
SELL | Selectin L | Cancer-related genes Candidate cardiovascular disease genes CD markers Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
SEPT1 | Septin 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
SIGLEC14 | Sialic acid binding Ig-like lectin 14 | Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
SIGLEC5 | Sialic acid binding Ig-like lectin 5 | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
SKAP1 | Src kinase associated phosphoprotein 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
SLC22A15 | Solute carrier family 22, member 15 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC9A5 | Solute carrier family 9, subfamily A (NHE5, cation proton antiporter 5), member 5 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SNCA | Synuclein, alpha (non A4 component of amyloid precursor) | Cytoskeleton related proteins Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins Transporters
| | | | | Tissue enhanced |
SNRPA1 | Small nuclear ribonucleoprotein polypeptide A' | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
SPN | Sialophorin | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
SPTB | Spectrin, beta, erythrocytic | Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
STAP1 | Signal transducing adaptor family member 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
TBC1D10C | TBC1 domain family, member 10C | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
TBX21 | T-box 21 | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |